Search - tctmd.com

Displaying 261 - 280 of 389

Sort: Relevancy | Date

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Conference News TCT 2015

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

October 13, 2015

News Conference News TCT 2015

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Yael L. Maxwell

October 13, 2015

News Conference News TCT 2015

INNOVATION Study Suggests Safety of Deferred Stenting

October 13, 2015

News Conference News TCT 2015

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Todd Neale

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Conference News TCT 2015

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

Presentation TCT 2015

Advanced CLI BTK Intervention: Two Cases From a Master Level Operator

Presenter: J. A. Mustapha, Craig M. Walker, Andrej Schmidt

October 11, 2015

Presentation TCT 2015

Approaching the Critical Limb Ischemia Endovascular Procedure: Planning Access, Tools, and Goals

Presenter: J. A. Mustapha, Craig M. Walker

October 11, 2015

Presentation TCT 2015

To Angiosome or Not to Angiosome? That Is the Question

Presenter: J. A. Mustapha, Craig M. Walker, Osamu Iida

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Presenter: Kevin J. Beatt, Craig R. Smith, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Presenter: J. A. Mustapha, Craig M. Walker, Gary M. Ansel

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron

October 11, 2015

Presentation TCT 2015

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

Presenter: Kevin J. Beatt, Craig R. Smith, Hemal Gada

October 11, 2015

Presentation TCT 2015

The BEST-CLI Study: Rationale and Update

Presenter: J. A. Mustapha, Craig M. Walker, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Perfusion Assessment in Critical Limb Ischemia in 2015

Presenter: J. A. Mustapha, Craig M. Walker, Mehdi H. Shishehbor

October 11, 2015

Presentation TCT 2015

The Team Approach to Critical Limb Ischemia: Who, How, and Why?

Presenter: J. A. Mustapha, Craig M. Walker, Alex Powell

October 11, 2015

Presentation TCT 2015

From COURAGE and BARI 2D to ISCHEMIA: What Answers Can We Expect (and Not Expect) From ISCHEMIA?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Sripal Bangalore

October 11, 2015

Presentation TCT 2015

Introduction: Why Is This Issue Important? Ischemia vs Bleeding

Presenter: Regina Deible, Roxana Mehran

October 11, 2015

Advertisement

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

INNOVATION Study Suggests Safety of Deferred Stenting

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Discussion Highlights Merits, Limitations of Small Trials

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Advanced CLI BTK Intervention: Two Cases From a Master Level Operator

Approaching the Critical Limb Ischemia Endovascular Procedure: Planning Access, Tools, and Goals

To Angiosome or Not to Angiosome? That Is the Question

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

The BEST-CLI Study: Rationale and Update

Perfusion Assessment in Critical Limb Ischemia in 2015

The Team Approach to Critical Limb Ischemia: Who, How, and Why?

From COURAGE and BARI 2D to ISCHEMIA: What Answers Can We Expect (and Not Expect) From ISCHEMIA?

Introduction: Why Is This Issue Important? Ischemia vs Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content